James Harrison Selected Research

James Harrison Research Topics

Disease

9	Atherosclerosis 11/2020 - 07/2012
8	Infections 01/2022 - 05/2017
6	Tuberculosis (Tuberculoses) 11/2021 - 01/2015
5	Atrial Fibrillation 04/2022 - 07/2012
5	Cicatrix (Scar) 12/2019 - 02/2014
3	Infarction (Infarctions) 01/2021 - 03/2013
3	Pain (Aches) 01/2019 - 01/2004
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 08/2013
3	Neoplasms (Cancer) 01/2016 - 05/2011
2	Abdominal Aortic Aneurysm 01/2019 - 11/2004
1	Ischemic Stroke 04/2022
1	False Aneurysm (Pseudoaneurysm) 01/2022
1	Multiple Sclerosis 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Pulmonary Embolism 01/2021
1	Persistent Infection 01/2021
1	Myocardial Infarction 01/2021
1	Ventricular Tachycardia 01/2021
1	Hemorrhage 01/2021
1	Granuloma 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Fibrosis (Cirrhosis) 10/2019
1	Aneurysm (Aneurysms) 01/2019
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2019
1	Aortic Rupture 01/2019
1	Fatigue 01/2019
1	Inflammation (Inflammations) 01/2019
1	Rupture 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Slipped Capital Femoral Epiphyses 06/2017
1	Hemolysis 05/2017
1	Cardiac Arrhythmias (Arrythmia) 04/2017
1	Death (Near-Death Experience) 01/2016
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Vascular Diseases (Vascular Disease) 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2013
1	Hyperlipidemias (Hyperlipidemia) 08/2013
1	Ovarian Neoplasms (Ovarian Cancer) 05/2011
1	Chronic Pain 09/2007
1	Ataxia (Dyssynergia) 09/2007
1	Anxiety Disorders (Anxiety Disorder) 10/2005
1	Alcohol-Related Disorders 10/2005
1	Mood Disorders (Mood Disorder) 10/2005

Drug/Important Bio-Agent (IBA)

6	GadoliniumIBA 01/2021 - 10/2015
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
3	CholesterolIBA 11/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
2	LDL Receptors (LDL Receptor)IBA 11/2019 - 01/2019
2	Apolipoproteins E (ApoE)IBA 01/2019 - 08/2013
2	EnzymesIBA 01/2019 - 01/2016
2	ApolipoproteinsIBA 02/2015 - 08/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014 - 08/2013
2	Mitochondrial DNA (mtDNA)IBA 03/2014 - 08/2013
1	Glatiramer Acetate (Copaxone)FDA Link 01/2022
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	NivolumabIBA 12/2020
1	IpilimumabIBA 12/2020
1	Triglycerides (Triacylglycerol)IBA 11/2020
1	relebactamIBA 01/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Autophagy-Related Protein 5IBA 01/2019
1	AntibodiesIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2019
1	InflammasomesIBA 01/2019
1	polycationsIBA 05/2017
1	MethacrylatesIBA 05/2017
1	Peptidoglycan (Murein)IBA 03/2015
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2015
1	LipidsIBA 01/2015
1	CarbohydratesIBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2013
1	B-Cell Activation Factor ReceptorIBA 07/2012
1	B-Cell Activating FactorIBA 07/2012
1	AntigensIBA 05/2011
1	WAY 132983IBA 09/2007
1	bicyclo(2.2.1)hepteneIBA 09/2007
1	Muscarinic AgonistsIBA 09/2007
1	Irritants (Vesicants)IBA 09/2007

Therapy/Procedure

5	Therapeutics 04/2022 - 05/2017
4	Catheter Ablation 10/2019 - 07/2012
3	Catheters 01/2022 - 12/2019
1	Massage (Zone Therapy) 01/2019
1	Osteotomy 06/2017
1	Palliative Care (Palliative Therapy) 01/2016
1	Aftercare (After-Treatment) 03/2013
1	Analgesia 09/2007